{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T13:11:14Z","timestamp":1792069874970,"version":"4.4.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,18]],"date-time":"2021-01-18T00:00:00Z","timestamp":1610928000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.eurox.2021.100121","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:44:35Z","timestamp":1611056675000},"page":"100121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis"],"prefix":"10.1016","volume":"10","author":[{"given":"Jane R.","family":"Schwebke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belvia A.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur S.","family":"Waldbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Agnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy R.A.","family":"Paull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-358X","authenticated-orcid":false,"given":"Clare F.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Castellarnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5570-2905","authenticated-orcid":false,"given":"Philip","family":"McCloud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George R.","family":"Kinghorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.eurox.2021.100121_bib0005","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/0002-9378(90)91186-G","article-title":"A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis","volume":"163","author":"Barbone","year":"1990","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eurox.2021.100121_bib0010","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1086\/503780","article-title":"High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence","volume":"193","author":"Bradshaw","year":"2006","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eurox.2021.100121_bib0015","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJM199512283332604","article-title":"Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group","volume":"333","author":"Hillier","year":"1995","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.eurox.2021.100121_bib0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11908-009-0021-7","article-title":"New concepts in the etiology of bacterial vaginosis","volume":"11","author":"Schwebke","year":"2009","journal-title":"Curr Infect Dis Rep"},{"issue":"9","key":"10.1016\/j.eurox.2021.100121_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074378","article-title":"The burden of bacterial vaginosis: women\u2019s experience of the physical, emotional, sexual and social impact of living with recurrent bacterial vaginosis","volume":"8","author":"Bilardi","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.eurox.2021.100121_bib0030","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/OLQ.0000000000000972","article-title":"High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis","volume":"46","author":"Peebles","year":"2019","journal-title":"Sex Transm Dis"},{"key":"10.1016\/j.eurox.2021.100121_bib0035","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.ajog.2005.11.041","article-title":"Suppressive antibacterial therapy with 0.75% metronidazole vaginal gel to prevent recurrent bacterial vaginosis","volume":"194","author":"Sobel","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eurox.2021.100121_bib0040","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ajog.2004.05.033","article-title":"Antimicrobial resistance associated with the treatment of bacterial vaginosis","volume":"191","author":"Beigi","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.eurox.2021.100121_bib0045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/cid\/cis1030","article-title":"Recurrence of bacterial vaginosis is significantly associated with posttreatment sexual activities and hormonal contraceptive use","volume":"56","author":"Bradshaw","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eurox.2021.100121_bib0050","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/s12879-015-1027-4","article-title":"Making inroads into improving treatment of bacterial vaginosis \u2013 striving for long-term cure","volume":"15","author":"Bradshaw","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"Suppl. 1","key":"10.1016\/j.eurox.2021.100121_bib0055","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1093\/infdis\/jiw159","article-title":"Current treatment of bacterial vaginosis - limitations and need for innovation","volume":"214","author":"Bradshaw","year":"2016","journal-title":"J Infect Dis"},{"issue":"5 Pt 1","key":"10.1016\/j.eurox.2021.100121_bib0060","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/01.AOG.0000183594.45524.d2","article-title":"Adherent biofilms in bacterial vaginosis","volume":"106","author":"Swidsinski","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"4","key":"10.1016\/j.eurox.2021.100121_bib0065","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/cid\/civ353","article-title":"Biofilms: an underappreciated mechanism of treatment failure and recurrence in vaginal infections","volume":"61","author":"Muzny","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eurox.2021.100121_bib0070","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3389\/fmicb.2015.01528","article-title":"Bacterial vaginosis biofilms: challenges to current therapies and emerging solutions","volume":"6","author":"Machado","year":"2016","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.eurox.2021.100121_bib0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/QAD.0b013e328346bd3e","article-title":"Phase 1 randomized trial of the vaginal safety and acceptability of SPL7013 Gel (VivaGel) in sexually active young women (MTN-004)","volume":"25","author":"McGowan","year":"2011","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.eurox.2021.100121_bib0080","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/OLQ.0b013e3181bc0aac","article-title":"Safety, tolerability, and pharmacokinetics of SPL7013 Gel (VivaGel): a dose-ranging, phase I study","volume":"37","author":"O\u2019Loughlin","year":"2010","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.eurox.2021.100121_bib0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232394","article-title":"A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose-ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis","volume":"15","author":"Waldbaum","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.eurox.2021.100121_bib0090","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejogrb.2019.11.032","article-title":"Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis","volume":"245","author":"Chavoustie","year":"2020","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.eurox.2021.100121_bib0095","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0002-9343(83)91112-9","article-title":"Nonspecific vaginitis; diagnostic criteria and microbial and epidemiologic associations","volume":"74","author":"Amsel","year":"1983","journal-title":"Am J Med"},{"key":"10.1016\/j.eurox.2021.100121_bib0100","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/jcm.29.2.297-301.1991","article-title":"Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation","volume":"29","author":"Nugent","year":"1991","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.eurox.2021.100121_bib0105","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/OLQ.0b013e3181b08456","article-title":"Boric acid addition to suppressive antimicrobial therapy for recurrent bacterial vaginosis","volume":"36","author":"Reichman","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"12","key":"10.1016\/j.eurox.2021.100121_bib0110","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1093\/infdis\/jiu818","article-title":"Randomized trial of periodic presumptive treatment with high-dose intravaginal metronidazole and miconazole to prevent vaginal infections in HIV-negative women","volume":"211","author":"McClelland","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eurox.2021.100121_bib0115","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","article-title":"Randomized trial of lactin-V to prevent recurrence of bacterial vaginosis","volume":"382","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"issue":"RR-03","key":"10.1016\/j.eurox.2021.100121_bib0120","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR-Morbid Mortal Weekly"},{"key":"10.1016\/j.eurox.2021.100121_bib0125","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1756287219832172","article-title":"An introduction to the epidemiology and burden of urinary tract infections","volume":"11","author":"Medina","year":"2019","journal-title":"Ther Adv Urol"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161321000016?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590161321000016?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T02:56:04Z","timestamp":1762916164000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590161321000016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":25,"alternative-id":["S2590161321000016"],"URL":"https:\/\/doi.org\/10.1016\/j.eurox.2021.100121","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.08.06.20159475","asserted-by":"object"}]},"ISSN":["2590-1613"],"issn-type":[{"value":"2590-1613","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phase 3, randomized, controlled trial of Astodrimer 1% Gel for preventing recurrent bacterial vaginosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eurox.2021.100121","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100121"}}